Pillstats
Labeler · US market

Concord Biotech Limited

Concord Biotech Limited is a US drug labeler with US FDA registrations covering 28 drug concepts (28 currently active) across 53 packages. It is currently the only active US supplier of 1 drug. The company files with FDA under 2 name variants, merged into this profile.

Also files as: CONCORD BIOTECH LTD

ACTIVE — US
openFDA · updated weekly
Labeler codes68254
Active drugs28
Registrations41 active / 41
Packages53
Sole supplier of1 drugs

Portfolio28 drugs · US

Every drug concept this labeler has US registrations for, by package count.

DrugTypeNDCsPackagesStatus
Tacrolimus
capsule
rx36SUPPLYING
Mycophenolic Acid
tablet, delayed release
rx24SUPPLYING
Mycophenolate Mofetil
powder
other44SUPPLYING
Mycophenolate Mofetil
tablet
rx13SUPPLYING
Tacrolimus
powder
other33SUPPLYING
Tacrolimus Premix 20 %
powder
other12SUPPLYING
Mycophenolate Mofetil
capsule
rx12SUPPLYING
Voclosporin
powder
other12SUPPLYING
Mycophenolate Sodium
powder
other22SUPPLYING
Cyclosporine
powder
other22SUPPLYING
Mupirocin
powder
other22SUPPLYING
Sirolimus
powder
other12SUPPLYING
Teriflunomide
tablet, film coated
rx22SUPPLYING
Mupirocin Calcium
powder
other22SUPPLYING
Temsirolimus
powder
other12SUPPLYING
Midostaurin
powder
other11SUPPLYING
Everolimus
powder
other11SUPPLYING
Pimecrolimus
powder
other11SUPPLYING
Micafungin Sodium
powder
other11SUPPLYING
Nystatin
powder
other11SUPPLYING
Fidaxomicin
powder
other11SUPPLYING
Pravastatin Sodium
powder
other11SUPPLYING
Mitomycin
powder
other11SUPPLYING
Vancomycin Hydrochloride
powder
other11SUPPLYING
Polymyxin B Sulfate
powder
other11SUPPLYING
Anidulafungin
powder
other11SUPPLYING
Dactinomycin
powder
other11SUPPLYING
Romidepsin
powder
other11SUPPLYING